CASI Pharmaceuticals
CASI
#10618
Rank
A$5.92 M
Marketcap
A$0.29
Share price
0.00%
Change (1 day)
-90.11%
Change (1 year)

Earnings for CASI Pharmaceuticals (CASI)

Earnings in 2025 (TTM): -A$73.7 Million

According to CASI Pharmaceuticals's latest financial reports the company's current earnings are A$26.84 Million. In 2024 the company made an earning of -A$52.94 Million a decrease over its 2023 earnings that were of -A$36.68 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CASI Pharmaceuticals from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$73.7 Million39.21%
2024 -A$52.94 Million44.35%
2023 -A$36.68 Million-29.55%
2022 -A$52.06 Million4.43%
2021 -A$49.85 Million-24.56%
2020 -A$66.07 Million4.74%
2019 -A$63.09 Million65.13%
2018 -A$38.21 Million155.07%
2017 -A$14.98 Million13.93%
2016 -A$13.15 Million31.18%
2015 -A$10.03 Million-72.5%
2014 -A$36.44 Million356.62%
2013 -A$7.98 Million-60.55%
2012 -A$20.23 Million218.41%
2011 -A$6.36 Million0.74%
2010 -A$6.31 Million-32.54%
2009 -A$9.35 Million-66.98%
2008 -A$28.31 Million-14.22%
2007 -A$33 Million7.04%
2006 -A$30.84 Million27.95%
2005 -A$24.1 Million4.51%
2004 -A$23.06 Million-15.84%
2003 -A$27.4 Million-55.29%
2002 -A$61.28 Million-34.05%
2001 -A$92.91 Million31.73%
2000 -A$70.53 Million31.56%
1999 -A$53.62 Million145.56%
1998 -A$21.84 Million76.4%
1997 -A$12.38 Million36.92%
1996 -A$9.04 Million